{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:55:40Z","timestamp":1751468140509},"publisher-location":"Berlin, Heidelberg","reference-count":83,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783540225690"},{"type":"electronic","value":"9783540276616"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005]]},"DOI":"10.1007\/3-540-27661-0_11","type":"book-chapter","created":{"date-parts":[[2005,11,2]],"date-time":"2005-11-02T21:06:13Z","timestamp":1130965573000},"page":"325-338","source":"Crossref","is-referenced-by-count":15,"title":["Homocysteine and B Vitamins"],"prefix":"10.1007","author":[{"given":"S.","family":"Cook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.M.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0021-9150(94)90078-7","volume":"106","author":"G. Alfthan","year":"1994","unstructured":"Alfthan G, Pekkanen J, Jauhiainen M, Pitkaniemi J, Karvonen M, Tuomilehto J, Salonen JT, Ehnholm C (1994) Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 106:9\u201319","journal-title":"Atherosclerosis"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(97)80014-1","volume":"349","author":"G. Alfthan","year":"1997","unstructured":"Alfthan G, Aro A, Gey KF (1997) Plasma homocysteine and cardiovascular disease mortality. Lancet 349:397","journal-title":"Lancet"},{"key":"11_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.atherosclerosis.2003.11.005","volume":"172","author":"M. Alvarez-Maqueda","year":"2004","unstructured":"Alvarez-Maqueda M, El Bekay R, Monteseirin J, Alba G, Chacon P, Vega A, Santa Maria C, Tejedo JR, Martin-Nieto J, Bedoya FJ (2004) Homocysteine enhances superoxide anion release and NADPH oxidase assembly by human neutrophils. Effects on MAPK activation and neutrophil migration. Atherosclerosis 172:229\u2013238","journal-title":"Atherosclerosis"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.CIR.102.11.1227","volume":"102","author":"J.L. Anderson","year":"2000","unstructured":"Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Madsen TE, Pearson RR (2000) Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation 102:1227\u20131232","journal-title":"Circulation"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.amjmed.2003.10.024","volume":"116","author":"J.L. Anderson","year":"2004","unstructured":"Anderson JL, Jensen KR, Carlquist JF, Bair TL, Horne BD, Muhlestein JB (2004) Effect of folic acid fortification of food on homocysteine-related mortality. Am J Med 116:158\u2013164","journal-title":"Am J Med"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/bmj.316.7135.894","volume":"316","author":"Anonymous","year":"1998","unstructured":"Anonymous (1998) Lowering blood homocysteine with folic acid based supplements: metaanalysis of randomised trials. Homocysteine Lowering Trialists\u2019 Collaboration. BMJ 316:894\u2013898","journal-title":"BMJ"},{"key":"11_CR7","first-page":"190","volume":"10","author":"Anonymous","year":"2003","unstructured":"Anonymous (2003) Konsensuspapier der D.A.C.H.-Liga Homocystein \u00fcber den rationalen klinischen Umgang mit Homocystein, Fols\u00e4ure und B-Vitaminen bei kardiovaskul\u00e4ren und thrombotischen Erkrankungen \u2014 Richtlinien und Empfehlungen. J Kardiol 10:190\u2013199","journal-title":"J Kardiol"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/ije\/24.4.704","volume":"24","author":"E. Arnesen","year":"1995","unstructured":"Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE (1995) Serumtotal homocysteine and coronary heart disease. Int J Epidemiol 24:704\u2013709","journal-title":"Int J Epidemiol"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"30808","DOI":"10.1074\/jbc.273.46.30808","volume":"273","author":"R.C. Austin","year":"1998","unstructured":"Austin RC, Sood SK, Dorward AM, Singh G, Shaughnessy SG, Pamidi S, Outinen PA, Weitz JI (1998) Homocysteine-dependent alterations in mitochondrial gene expression, function and structure. Homocysteine and H2O2 act synergistically to enhance mitochondrial damage. J Biol Chem 273:30808\u201330817","journal-title":"J Biol Chem"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/01.STR.0000060202.63475.BA","volume":"34","author":"H. Ay","year":"2003","unstructured":"Ay H, Arsava EM, Tokgozoglu SL, Ozer N, Saribas O (2003) Hyperhomocysteinemia is associated with the presence of left atrial thrombus in stroke patients with nonvalvular atrial fibrillation. Stroke 34:909\u2013912","journal-title":"Stroke"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/BF00293290","volume":"69","author":"G.H. Boers","year":"1985","unstructured":"Boers GH, Fowler B, Smals AG, Trijbels FJ, Leermakers AI, Kleijer WJ, Kloppenborg PW (1985) Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts. Hum Genet 69:164\u2013169","journal-title":"Hum Genet"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1001\/archinte.159.10.1077","volume":"159","author":"A.G. Bostom","year":"1999","unstructured":"Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D'Agostino RB, Wolf PA, Jacques PF, Wilson PW (1999) Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159:1077\u20131080","journal-title":"Arch Intern Med"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/archinte.159.1.38","volume":"159","author":"M.L. Bots","year":"1999","unstructured":"Bots ML, Launer LJ, Lindemans J, Hoes AW, Hofman A, Witteman JC, Koudstaal PJ, Grobbee DE (1999) Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med 159:38\u201344","journal-title":"Arch Intern Med"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/jama.274.13.1049","volume":"274","author":"C.J. Boushey","year":"1995","unstructured":"Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049\u20131057","journal-title":"JAMA"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1161\/01.STR.0000069017.78624.37","volume":"34","author":"G. Boysen","year":"2003","unstructured":"Boysen G, Brander T, Christensen H, Gideon R, Truelsen T (2003) Homocysteine and risk of recurrent stroke. Stroke 34:1258\u20131261","journal-title":"Stroke"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.STR.15.6.1012","volume":"15","author":"L.E. Brattstrom","year":"1984","unstructured":"Brattstrom LE, Hardebo JE, Hultberg BL (1984) Moderate homocysteinemia-a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke15:1012\u20131016","journal-title":"Stroke"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/00365518809167487","volume":"48","author":"L.E. Brattstrom","year":"1988","unstructured":"Brattstrom LE, Israelsson B, Jeppsson JO, Hultberg BL (1988) Folic acid-an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 48:215\u2013221","journal-title":"Scand J Clin Lab Invest"},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0140-6736(87)91772-7","volume":"1","author":"L. Brattstrom","year":"1987","unstructured":"Brattstrom L, Englund E, Brun A (1987) Does Down syndrome support homocysteine theory of arteriosclerosis? Lancet 1:391\u2013392","journal-title":"Lancet"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/0735-1097(93)90203-D","volume":"22","author":"D.S. Celermajer","year":"1993","unstructured":"Celermajer DS, Sorensen K, Ryalls M, Robinson J, Thomas O, Leonard JV, Deanfield JE (1993) Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol 22:854\u2013858","journal-title":"J Am Coll Cardiol"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/01.CIR.102.20.2479","volume":"102","author":"J.C. Chambers","year":"2000","unstructured":"Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS (2000) Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation 102:2479\u20132483","journal-title":"Circulation"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","volume":"324","author":"R. Clarke","year":"1991","unstructured":"Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324:1149\u20131155","journal-title":"N Engl J Med"},{"key":"11_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1472-8206.2002.00130.x","volume":"16","author":"S. Cook","year":"2002","unstructured":"Cook S, Scherrer U (2002) Insulin resistance, a new target for nitric oxide-delivery drugs. Fundam Clin Pharmacol 16:441\u2013453","journal-title":"Fundam Clin Pharmacol"},{"key":"11_CR23","unstructured":"Cook S, Schnyder G, Hess OM (2004) Plasma Homocysteine and Cardiovascular Events: Hype, Myth or Truth? Eur Heart J 25"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/sj.ejcn.1600467","volume":"51","author":"A. Bree de","year":"1997","unstructured":"de Bree A, van Dusseldorp M, Brouwer IA, van het Hof KH, Steegers-Theunissen RP (1997) Folate intake in Europe: recommended, actual and desired intake. Eur J Clin Nutr 51:643\u2013660","journal-title":"Eur J Clin Nutr"},{"key":"11_CR25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1056\/NEJM199603213341203","volume":"334","author":"M. Heijer den","year":"1996","unstructured":"den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759\u2013762","journal-title":"N Engl J Med"},{"key":"11_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.0022-3042.2001.00676.x","volume":"80","author":"W. Duan","year":"2002","unstructured":"Duan W, Ladenheim B, Cutler RG, Kruman, II, Cadet JL, Mattson MP (2002) Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J Neurochem 80:101\u2013110","journal-title":"J Neurochem"},{"key":"11_CR27","first-page":"155","volume":"100","author":"M.A. Flynn","year":"2003","unstructured":"Flynn MA, Singh A, Slaughter J, King P, Krause G, Herbert V, Thomas W (2003) Interrelationship of homocysteine-cobalamin-folate indices in human subjects of various ages: can hyper-homocyteinemia be relieved with B-12 supplementation? Mol Med 100:155\u2013158","journal-title":"Mol Med"},{"key":"11_CR28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1053\/euhj.1998.1340","volume":"20","author":"A. Gardemann","year":"1999","unstructured":"Gardemann A, Weidemann H, Philipp M, Katz N, Tillmanns H, Hehrlein FW, Haberbosch W (1999) The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease. Eur Heart J 20:584\u2013592","journal-title":"Eur Heart J"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0735-1097(90)90542-W","volume":"16","author":"J.J. Genest Jr.","year":"1990","unstructured":"Genest JJ, Jr., McNamara JR, Salem DN, Wilson PW, Schaefer EJ, Malinow MR (1990) Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol 16:1114\u20131119","journal-title":"J Am Coll Cardiol"},{"key":"11_CR30","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","volume":"277","author":"I.M. Graham","year":"1997","unstructured":"Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G, et al. (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277:1775\u20131781","journal-title":"JAMA"},{"key":"11_CR31","unstructured":"Guo H, Xing Y, Lee JD, Wang J, Hiroyasu U, Ueda T (2004) Changes of plasma homocysteine levels and arterial endothelial function in patients with unstable angina and interventional therapy of folic acid. Swiss Med Wkly. 134"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1056\/NEJM197409122911101","volume":"291","author":"L.A. Harker","year":"1974","unstructured":"Harker LA, Slichter SJ, Scott CR, Ross R (1974) Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med 291:537\u2013543","journal-title":"N Engl J Med"},{"key":"11_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1161\/hs0202.103069","volume":"33","author":"V.J. Howard","year":"2002","unstructured":"Howard VJ, Sides EG, Newman GC, Cohen SN, Howard G, Malinow MR, Toole JF (2002) Changes in plasma homocyst(e)ine in the acute phase after stroke. Stroke 33:473\u2013478","journal-title":"Stroke"},{"key":"11_CR34","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/bmj.316.7135.894","volume":"316","author":"Homocysteine Lowering Trialists","year":"1998","unstructured":"Homocysteine Lowering Trialists\u2019 Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 316:894\u2013898","journal-title":"BMJ"},{"key":"11_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0021-9150(88)90147-5","volume":"71","author":"B. Israelsson","year":"1988","unstructured":"Israelsson B, Brattstrom LE, Hultberg BL (1988) Homocysteine and myocardial infarction. Atherosclerosis 71:227\u2013233","journal-title":"Atherosclerosis"},{"key":"11_CR36","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1172\/JCI112461","volume":"77","author":"S.S. Kang","year":"1986","unstructured":"Kang SS, Wong PW, Cook HY, Norusis M, Messer JV (1986) Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. J Clin Invest 77:1482\u20131486","journal-title":"J Clin Invest"},{"key":"11_CR37","first-page":"414","volume":"43","author":"S.S. Kang","year":"1988","unstructured":"Kang SS, Zhou J, Wong PW, Kowalisyn J, Strokosch G (1988) Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43:414\u2013421","journal-title":"Am J Hum Genet"},{"key":"11_CR38","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0022-3476(99)70102-2","volume":"135","author":"L. Kapusta","year":"1999","unstructured":"Kapusta L, Haagmans ML, Steegers EA, Cuypers MH, Blom HJ, Eskes TK (1999) Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr 135:773\u2013774","journal-title":"J Pediatr"},{"key":"11_CR39","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1161\/01.STR.30.8.1554","volume":"30","author":"S.J. Kittner","year":"1999","unstructured":"Kittner SJ, Giles WH, Macko RF, Hebel JR, Wozniak MA, Wityk RJ, Stolley PD, Stern BJ, Sloan MA, Sherwin R, Price TR, McCarter RJ, Johnson CJ, Earley CJ, Buchholz DW, Malinow MR (1999) Homocyst(e)ine and risk of cerebral infarction in a biracial population: the stroke prevention in young women study. Stroke 30:1554\u20131560","journal-title":"Stroke"},{"key":"11_CR40","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1073\/pnas.83.7.2047","volume":"83","author":"J.P. Kraus","year":"1986","unstructured":"Kraus JP, Williamson CL, Firgaira FA, Yang-Feng TL, Munke M, Francke U, Rosenberg LE (1986) Cloning and screening with nanogram amounts of immunopurified mRNAs: cDNA cloning and chromosomal mapping of cystathionine beta-synthase and the beta subunit of propionyl-CoA carboxylase. Proc Natl Acad Sci USA 83:2047\u20132051","journal-title":"Proc Natl Acad Sci USA"},{"key":"11_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1006\/mgme.2000.2993","volume":"70","author":"W.D. Kruger","year":"2000","unstructured":"Kruger WD, Evans AA, Wang L, Malinow MR, Duell PB, Anderson PH, Block PC, Hess DL, Graf EE, Upson B (2000) Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Mol Genet Metab 70:53\u201360","journal-title":"Mol Genet Metab"},{"key":"11_CR42","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.20-18-06920.2000","volume":"20","author":"I.I. Kruman","year":"2000","unstructured":"Kruman, II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitoxicity. J Neurosci 20:6920\u20136926","journal-title":"J Neurosci"},{"key":"11_CR43","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-510X(97)00311-0","volume":"155","author":"W. Lalouschek","year":"1998","unstructured":"Lalouschek W, Aull S, Korninger L, Mannhalter C, Pabinger-Fasching I, Schmid RW, Schnider P, Zeiler K (1998) 677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke. J Neurol Sci 155:156\u2013162","journal-title":"J Neurol Sci"},{"key":"11_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainres.2003.10.027","volume":"996","author":"H. Lee","year":"2004","unstructured":"Lee H, Kim HJ, Kim J, Chang N (2004) Effects of dietary folic acid supplementation on cerebrovascular endothelial dysfunction in rats with induced hyperhomocysteinemia. Brain Res 996:139\u2013147","journal-title":"Brain Res"},{"key":"11_CR45","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJM199804093381501","volume":"338","author":"M.R. Malinow","year":"1998","unstructured":"Malinow MR, Duell PB, Hess DL, Anderson PH, Kruger WD, Phillipson BE, Gluckman RA, Block PC, Upson BM (1998) Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 338:1009\u20131015","journal-title":"N Engl J Med"},{"key":"11_CR46","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/ndt\/9.8.1103","volume":"9","author":"Z.A. Massy","year":"1994","unstructured":"Massy ZA, Chadefaux-Vekemans B, Chevalier A, Bader CA, Drueke TB, Legendre C, Lacour B, Kamoun P, Kreis H (1994) Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 9:1103\u20131108","journal-title":"Nephrol Dial Transplant"},{"key":"11_CR47","first-page":"111","volume":"56","author":"K.S. McCully","year":"1969","unstructured":"McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111\u2013128","journal-title":"Am J Pathol"},{"key":"11_CR48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.STR.32.1.57","volume":"32","author":"D.J. Meiklejohn","year":"2001","unstructured":"Meiklejohn DJ, Vickers MA, Dijkhuisen R, Greaves M (2001) Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke. Stroke 32:57\u201362","journal-title":"Stroke"},{"key":"11_CR49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1023\/A:1009652011466","volume":"5","author":"P. Mercie","year":"2000","unstructured":"Mercie P, Garnier O, Lascoste L, Renard M, Closse C, Durrieu F, Marit G, Boisseau RM, Belloc F (2000) Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features. Apoptosis 5:403\u2013411","journal-title":"Apoptosis"},{"key":"11_CR50","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.CIR.97.2.138","volume":"97","author":"A. Moustapha","year":"1998","unstructured":"Moustapha A, Naso A, Nahlawi M, Gupta A, Arheart KL, Jacobsen DW, Robinson K, Dennis VW (1998) Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 97:138\u2013141","journal-title":"Circulation"},{"key":"11_CR51","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/bmj.2.6081.226","volume":"2","author":"J.C. Murdoch","year":"1977","unstructured":"Murdoch JC, Rodger JC, Rao SS, Fletcher CD, Dunnigan MG (1977) Down's syndrome: an atheroma-free model? BMJ 2:226\u2013228","journal-title":"BMJ"},{"key":"11_CR52","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1001\/jama.274.19.1526","volume":"274","author":"O. Nygard","year":"1995","unstructured":"Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M, Kvale G (1995) Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274:1526\u20131533","journal-title":"JAMA"},{"key":"11_CR53","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM199707243370403","volume":"337","author":"O. Nygard","year":"1997","unstructured":"Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230\u2013236","journal-title":"N Engl J Med"},{"key":"11_CR54","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0891-5849(93)90151-J","volume":"14","author":"A.J. Olszewski","year":"1993","unstructured":"Olszewski AJ, McCully KS (1993) Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Radic Biol Med 14:683\u2013693","journal-title":"Free Radic Biol Med"},{"key":"11_CR55","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/S0140-6736(95)92407-8","volume":"346","author":"I.J. Perry","year":"1995","unstructured":"Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG (1995) Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346:1395\u20131398","journal-title":"Lancet"},{"key":"11_CR56","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(96)03032-2","volume":"348","author":"M. Petri","year":"1996","unstructured":"Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J, Rosenberg IH (1996) Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 348:1120\u20131124","journal-title":"Lancet"},{"key":"11_CR57","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1046\/j.1365-2796.2003.01096.x","volume":"253","author":"L. Retterstol","year":"2003","unstructured":"Retterstol L, Paus B, Bohn M, Bakken A, Erikssen J, Malinow MR, Berg K (2003) Plasma total homocysteine levels and prognosis in patients with previous premature myocardial infarction: a 10-year follow-up study. J Intern Med 253:284\u2013292","journal-title":"J Intern Med"},{"key":"11_CR58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/qjmed\/95.1.27","volume":"95","author":"A. Rydlewicz","year":"2002","unstructured":"Rydlewicz A, Simpson JA, Taylor RJ, Bond CM, Golden MH (2002) The effect of folic acid supplementation on plasma homocysteine in an elderly population. QJM 95:27\u201335","journal-title":"QJM"},{"key":"11_CR59","doi-asserted-by":"publisher","first-page":"15227","DOI":"10.1073\/pnas.93.26.15227","volume":"93","author":"T.H. Rosenquist","year":"1996","unstructured":"Rosenquist TH, Ratashak SA, Selhub J (1996) Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA 93:15227\u201315232","journal-title":"Proc Natl Acad Sci USA"},{"key":"11_CR60","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-510X(02)00210-1","volume":"202","author":"Y. Sato","year":"2002","unstructured":"Sato Y, Kaji M, Kondo I, Yoshida H, Satoh K, Metoki N (2002) Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: effect of combined therapy with folic acid and mecobalamine. J Neurol Sci 202:65\u201368","journal-title":"J Neurol Sci"},{"key":"11_CR61","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0002-9149(01)01983-X","volume":"88","author":"G. Schnyder","year":"2001","unstructured":"Schnyder G, Pin R, Roffi M, Flammer Y, Hess OM (2001) Association of plasma homocysteine with the number of major coronary arteries severely narrowed. Am J Cardiol 88:1027\u20131030","journal-title":"Am J Cardiol"},{"key":"11_CR62","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1001\/jama.288.8.973","volume":"288","author":"G. Schnyder","year":"2002","unstructured":"Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM (2002) Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA 288:973\u2013979","journal-title":"JAMA"},{"key":"11_CR63","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMoa011613","volume":"346","author":"S. Seshadri","year":"2002","unstructured":"Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346:476\u2013383","journal-title":"N Engl J Med"},{"key":"11_CR64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.nu.05.070185.000555","volume":"5","author":"B. Shane","year":"1985","unstructured":"Shane B, Stokstad EL (1985) Vitamin B12-folate interrelationships. Annu Rev Nutr 5:115\u2013141","journal-title":"Annu Rev Nutr"},{"key":"11_CR65","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0895-7061(99)00058-8","volume":"12","author":"Y. Sharabi","year":"1999","unstructured":"Sharabi Y, Doolman R, Rosenthal T, Grossman E, Rachima-Maoz C, Nussinovitch N, Sela B (1999). Homocysteine levels in hypertensive patients with a history of cardiac or cerebral atherothrombotic events. Am J Hypertens 12:766\u2013771","journal-title":"Am J Hypertens"},{"key":"11_CR66","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1073\/pnas.89.16.7674","volume":"89","author":"J.S. Stamler","year":"1992","unstructured":"Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, Loscalzo J (1992) Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 89:7674\u20137677","journal-title":"Proc Natl Acad Sci USA"},{"key":"11_CR67","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","volume":"268","author":"M.J. Stampfer","year":"1992","unstructured":"Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH (1992) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268:877\u2013881","journal-title":"JAMA"},{"key":"11_CR68","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1161\/hs1201.099650","volume":"32","author":"J.Y. Streifler","year":"2001","unstructured":"Streifler JY, Rosenberg N, Chetrit A, Eskaraev R, Sela BA, Dardik R, Zivelin A, Ravid B, Davidson J, Seligsohn U, Inbal A (2001) Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism. Stroke 32:2753\u20132758","journal-title":"Stroke"},{"key":"11_CR69","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.atherosclerosis.2003.10.003","volume":"172","author":"M. Syvanne","year":"2004","unstructured":"Syvanne M, Whittall RA, Turpeinen U, Nieminen MS, Frick MH, Kesaniemi YA, Pasternack A, Humphries SE, Taskinen M-R (2004) Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis. Atherosclerosis 172:267\u2013272","journal-title":"Atherosclerosis"},{"key":"11_CR70","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/01.STR.0000060203.58958.35","volume":"34","author":"D. Tanne","year":"2003","unstructured":"Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y, Brunner D, Behar S, Sela BA (2003) Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke 34:632\u2013636","journal-title":"Stroke"},{"key":"11_CR71","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S0735-1097(00)00809-3","volume":"36","author":"L.M. Title","year":"2000","unstructured":"Title LM, Cummings PM, Giddens K, Genest JJ, Jr., Nassar BA (2000) Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol 36:758\u2013765","journal-title":"J Am Coll Cardiol"},{"key":"11_CR72","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2362.1995.tb01545.x","volume":"25","author":"M. Berg Van den","year":"1995","unstructured":"Van den Berg M, Boers GH, Franken DG, Blom HJ, Van Kamp GJ, Jakobs C, Rauwerda JA, Kluft C, Stehouwert CD (1995) Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin Invest 25:176\u2013181","journal-title":"Eur J Clin Invest"},{"key":"11_CR73","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1161\/01.STR.25.10.1924","volume":"25","author":"P. Verhoef","year":"1994","unstructured":"Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ (1994) A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 25:1924\u20131930","journal-title":"Stroke"},{"key":"11_CR74","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/oxfordjournals.aje.a008828","volume":"143","author":"P. Verhoef","year":"1996","unstructured":"Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC (1996) Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 143:845\u2013859","journal-title":"Am J Epidemiol"},{"key":"11_CR75","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.ATV.17.5.989","volume":"17","author":"P. Verhoef","year":"1997","unstructured":"Verhoef P, Kok FJ, Kruyssen DA, Schouten EG, Witteman JC, Grobbee DE, Ueland PM, Refsum H (1997) Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 17:989\u2013995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"11_CR76","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0021-9150(97)00084-1","volume":"132","author":"P. Verhoef","year":"1997","unstructured":"Verhoef P, Kok FJ, Kluijtmans LA, Blom HJ, Refsum H, Ueland PM, Kruyssen DA (1997) The 677C\u2192T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis 132:105\u2013113","journal-title":"Atherosclerosis"},{"key":"11_CR77","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.STR.0000052631.98405.15","volume":"34","author":"S.E. Vermeer","year":"2003","unstructured":"Vermeer SE, Den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM (2003) Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 34:392\u2013396","journal-title":"Stroke"},{"key":"11_CR78","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(99)07391-2","volume":"355","author":"E.G. Vermeulen","year":"2000","unstructured":"Vermeulen EG, Stehouwer CD, Twisk JW, van den Berg M, de Jong SC, Mackaay AJ, van Campen CM, Visser FC, Jakobs CA, Bulterjis EJ, Rauwerda JA (2000) Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet 355:517\u2013522","journal-title":"Lancet"},{"key":"11_CR79","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/archinte.158.8.862","volume":"158","author":"N.J. Wald","year":"1998","unstructured":"Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM (1998) Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med 158:862\u2013867","journal-title":"Arch Intern Med"},{"key":"11_CR80","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","volume":"338","author":"G.N. Welch","year":"1998","unstructured":"Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338:1042\u20131050","journal-title":"N Engl J Med"},{"key":"11_CR81","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-8628(20000103)90:1<12::AID-AJMG3>3.0.CO;2-H","volume":"90","author":"K.D. Wenstrom","year":"2000","unstructured":"Wenstrom KD, Johanning GL, Owen J, Johnston KE, Acton S, Tamura T (2000) Role of amniotic fluid homocysteine level and of fetal 5, 10-methylenetetrahydrafolate reductase genotype in the etiology of neural tube defects. Am J Med Genet 90:12\u201316","journal-title":"Am J Med Genet"},{"key":"11_CR82","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1172\/JCI108350","volume":"57","author":"D.E. Wilcken","year":"1976","unstructured":"Wilcken DE, Wilcken B (1976) The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 57:1079\u20131082","journal-title":"J Clin Invest"},{"key":"11_CR83","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/clinchem\/40.4.552","volume":"40","author":"L.L. Wu","year":"1994","unstructured":"Wu LL, Wu J, Hunt SC, James BC, Vincent GM, Williams RR, Hopkins PN (1994) Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem 40:552\u2013561","journal-title":"Clin Chem"}],"container-title":["Handbook of Experimental Pharmacology","Atherosclerosis: Diet and Drugs"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/3-540-27661-0_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T16:37:47Z","timestamp":1586536667000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/3-540-27661-0_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"ISBN":["9783540225690","9783540276616"],"references-count":83,"URL":"https:\/\/doi.org\/10.1007\/3-540-27661-0_11","relation":{},"ISSN":["0171-2004"],"issn-type":[{"type":"print","value":"0171-2004"}],"subject":[],"published":{"date-parts":[[2005]]}}}